Clinical Trial Update: A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together. [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether co-administration of fluoxetine and LY2216684 alters their pharmacokinetics, indicating potential drug–drug interaction in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Prozac) (Fluoxetine)
• LY2216684

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-22